We studied 23 adults in Latvia who had extrapyramidal symptoms and who had injected methcathinone for a mean (±SD) of 6.7±5.1 years. The methcathinone was manufactured under home conditions by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results